REQUEST A DEMO
Total
USD $0.00
Search more companies

Kimyagaran Emrooz Chemical Industries Company Public Joint Stock (Iran)

Main Activities: Chemical Manufacturing
Full name: Kimyagaran Emrooz Chemical Industries Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Kimyagaran Emrooz Chemical Industries Co. is recognized as one of the major leading production enterprises in the ethoxylation and propoxylation industry for the production of a wide variety of chemicals and pharmaceuticals in the Middle East. The company started with the production of pharmaceutical polyethene glycols (PEGs). Currently, after long-term effort and hard work leading to develop own know-how and technology, Kimyagaran Emrooz is the leading manufacturer of various ethoxylated and propoxylated products which are consumed in 17 different industrial branches.

Headquarters
North Sohrevardi Ave, No. 133, West Hoveyzeh St
Tehran; Tehran;

Contact Details: Purchase the Kimyagaran Emrooz Chemical Industries Company Public Joint Stock report to view the information.

Website: http://www.kimyagaran.com

Basic Information
Total Employees:
Purchase the Kimyagaran Emrooz Chemical Industries Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Kimyagaran Emrooz Chemical Industries Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Kimyagaran Emrooz Chemical Industries Company Public Joint Stock report to view the information.
Incorporation Date:
1995
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
48%
Purchase this report to view the information.
6%
Purchase this report to view the information.
3%
Purchase this report to view the information.
3%
Purchase this report to view the information.
0.7%
Subsidiaries
Parand Daro Pharmaceutical Company
Company Performance
Financial values in the chart are available after Kimyagaran Emrooz Chemical Industries Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
38.62%
Total operating revenue
38.36%
Operating profit (EBIT)
18.4%
EBITDA
20.85%
Net Profit (Loss) for the Period
10.97%
Total assets
38.25%
Total equity
54.32%
Operating Profit Margin (ROS)
-3.46%
Net Profit Margin
-3.45%
Return on Equity (ROE)
-12.67%
Debt to Equity Ratio
-15.55%
Quick Ratio
0.04%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?